| |
own homes
|
NH replacement
|
F-values
|
covariance
|
|---|
| |
no DNP
|
DNP
|
no DNP
|
DNP
|
NH
|
DNP
|
interact
|
age
|
sex
|
|---|
|
AD
|
n = 25
|
n = 27
|
n = 6
|
n = 7
| | | | | |
|---|
|
lifetime expectancy
|
56.3 (44.6)
|
84.7 (36.3)
|
122.5 (59.7)
|
156.4 (37.8)
|
20.442***
|
4.704*
|
0.002
|
0.873
|
2.482
|
|
QALY
|
26.4 (17.8)
|
47.0 (20.5)
|
53.1 (18.2)
|
75.7 (18.5)
|
15.123***
|
11.859***
|
0.000
|
0.854
|
3.738
|
|
AD with CVD
|
n = 9
|
n = 14
|
n = 8
|
n = 4
| | | | | |
|
lifetime expectancy
|
49.9 (41.6)
|
77.6 (32.9)
|
57.5 (44.6)
|
119.0 (46.2)
|
2.207
|
7.861**
|
1.034
|
0.265
|
0.364
|
|
QALY
|
30.4 (21.3)
|
41.9 (16.1)
|
30.8 (27.1)
|
54.4 (29.4)
|
0.74
|
3.608
|
0.65
|
0.077
|
2.162
|
- Two-way ANOVAs with the covariance of age and gender were performed
- *p < 0.05, **p < 0.01, ***p < 0.001
- AD Alzheimer's disease, CVD cerebrovascular diseases, QALY quality-adusted life-year
- DNP donepezil, NH nursing home
